Most progression free survival related news are at:
More progression free survival related news:
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.com.ar 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.co.nz 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.com.br 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.sg 18 Jun 2012 | 12:53 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.my 18 Jun 2012 | 12:53 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.ae 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.co.za 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.co.uk 18 Jun 2012 | 12:48 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.mx 18 Jun 2012 | 12:53 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at the European Hematology Association (EHA) Annual Congress crwenewswire.mx 18 Jun 2012 | 12:53 am
Investigational agent ibrutinib demonstrates prolonged progression-free survival (PFS) AMSTERDAM (CRWENewswire - June 16, 2012) — Pharmacyclics, Inc (Nasdaq:PCYC) announced today at the 17th Congress ...
